Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
Article 9
In force · version of Jan 1, 2025
In addition to the requirements set out in Articles 8 and 10(1), an application for authorization to market a radionuclide generator shall also contain the following information and particulars:
— a general description of the system together with a detailed description of the components of the system which may affect the composition or quality of the daughter nucleid preparation,
— qualitative and quantitative particulars of the eluate or the sublimate.